These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23119114)

  • 21. Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma.
    Wang H; Wu Q; Liu Z; Luo X; Fan Y; Liu Y; Zhang Y; Hua S; Fu Q; Zhao M; Chen Y; Fang W; Lv X
    Cell Death Dis; 2014 Apr; 5(4):e1155. PubMed ID: 24722280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FLOT-2 is an independent prognostic marker in oral squamous cell carcinoma.
    Wen Q; Alnemah MM; Luo J; Wang W; Chu S; Chen L; Li J; Xu L; Li M; Zhou J; Fan S
    Int J Clin Exp Pathol; 2015; 8(7):8236-43. PubMed ID: 26339392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased expression of MCM5 is significantly associated with aggressive progression and poor prognosis of oral squamous cell carcinoma.
    Yu SY; Wang YP; Chang JY; Shen WR; Chen HM; Chiang CP
    J Oral Pathol Med; 2014 May; 43(5):344-9. PubMed ID: 24245508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic and predictive values of SPP1, PAI and caveolin-1 in patients with oral squamous cell carcinoma.
    Huang CF; Yu GT; Wang WM; Liu B; Sun ZJ
    Int J Clin Exp Pathol; 2014; 7(9):6032-9. PubMed ID: 25337248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An immunohistochemical study of thrombomodulin in oral squamous cell carcinoma and its association with invasive and metastatic potential.
    Tabata M; Sugihara K; Yonezawa S; Yamashita S; Maruyama I
    J Oral Pathol Med; 1997 Jul; 26(6):258-64. PubMed ID: 9234185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The expression and significance of MRP1, LRP, TOPOIIβ, and BCL2 in tongue squamous cell carcinoma.
    Zhang B; Liu M; Tang HK; Ma HB; Wang C; Chen X; Huang HZ
    J Oral Pathol Med; 2012 Feb; 41(2):141-8. PubMed ID: 21793937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ets-1: a plausible marker of invasive potential and lymph node metastasis in human oral squamous cell carcinomas.
    Pande P; Mathur M; Shukla NK; Ralhan R
    J Pathol; 1999 Sep; 189(1):40-5. PubMed ID: 10451486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant expression of β-catenin and its association with ΔNp63, Notch-1, and clinicopathological factors in oral squamous cell carcinoma.
    Ravindran G; Devaraj H
    Clin Oral Investig; 2012 Aug; 16(4):1275-88. PubMed ID: 21881870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical and FISH analysis of EGFR and its prognostic value in patients with oral squamous cell carcinoma.
    Gröbe A; Eichhorn W; Fraederich M; Kluwe L; Vashist Y; Wikner J; Smeets R; Simon R; Sauter G; Heiland M; Blessmann M
    J Oral Pathol Med; 2014 Mar; 43(3):205-10. PubMed ID: 24020871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormalities of molecular regulators of proliferation and apoptosis in carcinoma of the oral cavity and oropharynx.
    Kuropkat C; Venkatesan TK; Caldarelli DD; Panje WR; Hutchinson J; Preisler HD; Coon JS; Werner JA
    Auris Nasus Larynx; 2002 Apr; 29(2):165-74. PubMed ID: 11893452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PTEN/PI3K/AKT protein expression is related to clinicopathological features and prognosis in breast cancer with axillary lymph node metastases.
    Wang LL; Hao S; Zhang S; Guo LJ; Hu CY; Zhang G; Gao B; Zhao JJ; Jiang Y; Tian WG; Wang J; Luo DL
    Hum Pathol; 2017 Mar; 61():49-57. PubMed ID: 27864123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PTEN and p16 genes as epigenetic biomarkers in oral squamous cell carcinoma (OSCC): a study on south Indian population.
    Sushma PS; Jamil K; Kumar PU; Satyanarayana U; Ramakrishna M; Triveni B
    Tumour Biol; 2016 Jun; 37(6):7625-32. PubMed ID: 26687648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of vascular endothelial growth factor-C predicts regional lymph node metastasis in early oral squamous cell carcinoma.
    Kishimoto K; Sasaki A; Yoshihama Y; Mese H; Tsukamoto G; Matsumura T
    Oral Oncol; 2003 Jun; 39(4):391-6. PubMed ID: 12676260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biomarkers predictive of lymph node metastases in oral squamous cell carcinoma.
    Lopes MA; Nikitakis NG; Reynolds MA; Ord RA; Sauk J
    J Oral Maxillofac Surg; 2002 Feb; 60(2):142-7; discussion 147-8. PubMed ID: 11815908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Up-regulation of SIBLING proteins and correlation with cognate MMP expression in oral cancer.
    Ogbureke KU; Nikitakis NG; Warburton G; Ord RA; Sauk JJ; Waller JL; Fisher LW
    Oral Oncol; 2007 Oct; 43(9):920-32. PubMed ID: 17306612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.
    Ren HZ; Pan GQ; Wang JS; Wen JF; Wang KS; Luo GQ; Shan XZ
    Dig Dis Sci; 2010 Sep; 55(9):2552-60. PubMed ID: 20108042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of CD163, interleukin-10, and interferon-gamma in oral squamous cell carcinoma: mutual relationships and prognostic implications.
    Wang S; Sun M; Gu C; Wang X; Chen D; Zhao E; Jiao X; Zheng J
    Eur J Oral Sci; 2014 Jun; 122(3):202-9. PubMed ID: 24796206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The expression of phospho-AKT1 and phospho-MTOR is associated with a favorable prognosis independent of PTEN expression in intrahepatic cholangiocarcinomas.
    Lee D; Do IG; Choi K; Sung CO; Jang KT; Choi D; Heo JS; Choi SH; Kim J; Park JY; Cha HJ; Joh JW; Choi KY; Kim DS
    Mod Pathol; 2012 Jan; 25(1):131-9. PubMed ID: 21874010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclo-oxygenase-2 expression is associated with vascular endothelial growth factor C expression and lymph node metastasis in oral squamous cell carcinoma.
    Kono M; Watanabe M; Abukawa H; Hasegawa O; Satomi T; Chikazu D
    J Oral Maxillofac Surg; 2013 Oct; 71(10):1694-702. PubMed ID: 23809761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ANGPTL4 regulates the metastatic potential of oral squamous cell carcinoma.
    Tanaka J; Irié T; Yamamoto G; Yasuhara R; Isobe T; Hokazono C; Tachikawa T; Kohno Y; Mishima K
    J Oral Pathol Med; 2015 Feb; 44(2):126-33. PubMed ID: 25060575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.